nach oben

Erschienen in:

01.03.2023 | Case report

Enfortumab-vedotin/pembrolizumab

Maculopapular rash, worsening of peripheral neuropathy and lack of efficacy : case report

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

…

Plimack ER, et al. Platinum-Free Systemic Therapy in First-Line Metastatic Urothelial Carcinoma: Mirage or Oasis in the Platinum Desert?. Journal of Clinical Oncology 41: 7-10, No. 1, Jan 2023. Available from: URL: https://ascopubs.org/doi/full/10.1200/JCO.22.01992?role=tab

Titel: Enfortumab-vedotin/pembrolizumab
Maculopapular rash, worsening of peripheral neuropathy and lack of efficacy : case report
Publikationsdatum: 01.03.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-34831-8